Medacta International Competitors and Similar CompaniesClear all

Medacta International's competitors and similar companies include Haemonetics, Orthofix and Livanova.

	Medacta International Medacta (also known as Medacta International) is a company that develops and manufactures medical devices for orthopedic and spine surgery.	Haemonetics Haemonetics is a provider of medical products and solutions.	Orthofix Orthofix Medical (formerly Orthofix International) is a company that provides specialized orthopedic solutions and a surgical navigation system.	Livanova LivaNova is a global medical technology company.
Founding Date	Founding Date 1999	Founding Date 1971	Founding Date 1980	Founding Date 2015
Type	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare medical devices medtech surgical solutions	Tags Healthcare medical devices medtech surgical solutions
Locations	Locations Castel San Pietro, CH HQ Lane Cove West, AU Straß In Steiermark, AT Nivelles, BE Kitchener, CA Nanterre, FR Göppingen, DE see more	Locations Boston, US HQ North Ryde, AU Edmonton, CA Québec, CA Beijing, CN Shanghai, CN Brno, CZ see more	Locations Lewisville, US HQ Barangaroo, AU Sao Paulo, BR Toronto, CA Arcueil, FR Paris, FR Laichingen, DE see more	Locations London, GB HQ Dandenong South, AU Wien, AT Markham, CA Bogotá, CO Helsinki, FI Helsinki, FI see more
Employees	Employees 809	Employees 3,65721% increase	Employees 1,63450% increase	Employees 2,900
Valuation ($)	Valuation ($) N/A	Valuation ($) 3.7 b	Valuation ($) 624.5 m	Valuation ($) 2.9 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $1.3b (FY, 2026)	Revenue (est.) $822.3m (FY, 2025)	Revenue (est.) $1.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $546.4m (FY, 2026)	Cost of goods $256.3m (FY, 2025)	Cost of goods $448.2m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $787.6m (FY, 2026)	Gross profit $566m (FY, 2025)	Gross profit $939.9m (FY, 2025)
Net income	Net income N/A	Net income $97.3m (FY, 2026)	Net income ($92.2m) (FY, 2025)	Net income ($242.5m) (FY, 2025)